Fran Supek

Researchers develop a tool to predict which tumour patients will benefit from immunotherapy

European researchers have developed an algorithm that identifies genetic alterations that trigger the immune system, helping distinguish which cancer patients are more likely to benefit from immunotherapy. This algorithm also predicts which people affected by hereditary diseases may profit from treatments with commercially available medications.

Continue Reading